Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.009 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
21-Nov-2013Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemiaFerreira, Pedro G.; Jares Gerboles, Pedro; Rico, Daniel; Gómez López, Gonzalo; Martínez Trillos, Alejandra; Villamor i Casas, Neus; Ecker, Simone; González-Pérez, Abel; Knowles, David G.; Monlong, Jean; Johnson, Rory; Quesada, Victor; Djebali, Sarah; Papasaikas, Panagiotis; López-Guerra, Mónica; Colomer Pujol, Dolors; Royo Moreno, Cristina; Cazorla, Maite; Pinyol, Magda; Clot, Guillem; Aymerich Gregorio, Marta; Rozman, María; Kulis, Marta; Tamborero Noguera, David; Gouin, Anaïs; Blanc, Julie; Gut, Marta; Gut, Ivo G.; Puente, Xose S.; Pisano, David G.; Martín-Subero, José Ignacio; López Bigas, Núria; López Guillermo, Armando; Valencia, Alfonso; López-Otin, Carlos; Campo Güerri, Elias; Guigó Serra, Roderic
8-Jun-2015The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaXargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Montraveta, Arnau; Roldán, Jocabed; Rodríguez, Vanina; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Lagisetti, Chandraiah; Webb, Thomas R.; López-Otin, Carlos; Campo Güerri, Elias; Colomer Pujol, Dolors
19-Dec-2015CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemiaMontraveta, Arnau; Lee-Vergés, Eriong; Roldán, Jocabed; Jiménez, Laura; Cabezas, Sandra; Clot, Guillem; Pinyol, Magda; Xargay i Torrent, Sílvia; Rosich, Laia; Arimany Nardi, Cristina; Aymerich Gregorio, Marta; Villamor i Casas, Neus; López Guillermo, Armando; Pérez Galán, Patricia; Roué, Gaël; Pastor Anglada, Marçal; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors
Mar-2019Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaGiménez Carabaza, Neus; Martínez Trillos, Alejandra; Montraveta, Arnau; López-Guerra, Mónica; Rosich, Laia; Nadeu, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio (Delgado González); Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, Maria José; Navarro, Blanca; Colado, Enrique; Payer, Ángel R.; Puente, Xose S.; López-Otin, Carlos; López Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus
Sep-2017Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifierNavarro, Alba; Clot, Guillem; Martínez Trillos, Alejandra; Pinyol, Magda; Jares Gerboles, Pedro; González Farré, Blanca; Martínez, Daniel; Trim, Nicola; Fernàndez Pascual, Verònica; Villamor i Casas, Neus; Colomer Pujol, Dolors; Costa, Dolors; Salaverria Frigola, Itziar; Martín García, David; Erber, Wendy; López, Cristina; Jayne, Sandrine; Siebert, Reiner; Dyer, Martin J. S.; Wiestner, Adrian; Wilson, Wyndham H.; Aymerich Gregorio, Marta; López Guillermo, Armando; Sànchez, Àlex (Sànchez Pla); Campo Güerri, Elias; Matutes, Estella; Beà Bobet, Sílvia M.
Nov-2014Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.Delgado, Julio (Delgado González); Salaverria Frigola, Itziar; Baumann, Tycho; Martínez Trillos, Alejandra; Lee, Eriong; Jiménez, Laura; Navarro López, Alba; Royo Moreno, Cristina; Santacruz, Rodrigo; López, Cristina; Payer, Ángel R.; Colado, Enrique; González, Marcos; Armengol, Lluís; Colomer Pujol, Dolors; Pinyol, Magda; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Carrió, Ana; Costa, Dolors; Clot, Guillem; Giné Soca, Eva; López Guillermo, Armando; Campo Güerri, Elias; Beà Bobet, Sílvia M.
May-2014The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.Santacruz, Rodrigo; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Martínez Trillos, Alejandra; López, Cristina; Navarro López, Alba; Rozman, María; Beà Bobet, Sílvia M.; Royo Moreno, Cristina; Cazorla, Maite; Colomer Pujol, Dolors; Giné Soca, Eva; Pinyol, Magda; Puente, Xose S.; López-Otin, Carlos; Campo Güerri, Elias; López Guillermo, Armando; Delgado, Julio (Delgado González)
15-Oct-2019Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cellsLópez-Guerra, Mónica; Xargay i Torrent, Sílvia; Fuentes, Patricia; Roldán, Jocabed; González Farré, Blanca; Rosich, Laia; Silkenstedt, Elisabeth; García León, María J.; Lee-Vergés, Eriong; Giménez Carabaza, Neus; Giró, Ariadna; Aymerich Gregorio, Marta; Villamor i Casas, Neus; Delgado, Julio; López Guillermo, Armando; Puente, Xose S.; Campo Güerri, Elias; Toribio, María L.; Colomer Pujol, Dolors